Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT02873169
Previous Study | Return to List | Next Study

Determination of Risk Factors of Ventricular Arrhythmias (VAs) After Implantation of Continuous Flow Left Ventricular Assist Device With Continuous Flow Left Ventricular Assist Device (CF-LVAD) (ASSIST-ICD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02873169
Recruitment Status : Completed
First Posted : August 19, 2016
Last Update Posted : October 20, 2017
Sponsor:
Information provided by (Responsible Party):
Rennes University Hospital

Brief Summary:
Determination of risk factors of ventricular arrhythmias (VAs) after implantation of continuous flow left ventricular assist device in order to characterize which patient requires ICD implantation in primary prevention.

Condition or disease Intervention/treatment
Severe Cardiac Insufficiency Other: Implantable cardioverter-defibrillator

Layout table for study information
Study Type : Observational
Actual Enrollment : 681 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Interest of Implantable Cardioverter-defibrillator in Primary Prevention in Patient With Continuous Flow Left Ventricular Assist Device (CF-LVAD)
Study Start Date : September 2015
Actual Primary Completion Date : December 31, 2016
Actual Study Completion Date : December 31, 2016

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: Implantable cardioverter-defibrillator
    Collection of clinical, biological, hemodynamic and rhythmic data


Primary Outcome Measures :
  1. Occurrence of early VAs (<30 days post operatively) and late VAs (>30 days post operatively) in patient with CF-LVAD with or without ICD [ Time Frame: 30 days ]
    Clinical, biological, hemodynamic and rhythmic data


Secondary Outcome Measures :
  1. Mortality in patients with CF-LVAD with or without VAs [ Time Frame: 30 days ]
  2. Mortality in patients with CF-LVAD with or without ICD [ Time Frame: 30 days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patient with continuous flow left ventricular assist device
Criteria

Inclusion Criteria:

  • Patient above 18 years old
  • Patients with CF-LVAD with or without ICD

Exclusion Criteria:

  • Patients subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02873169


Locations
Layout table for location information
France
CHU de Bordeaux
Bordeaux, France, 33600
Hospices Civils de Lyon - Hôpital Louis Pradel
Bron, France, 69677
CHU de Caen
Caen, France
CHU Clermont Ferrand
Clermont Ferrand, France, 63003
Hôpital Henri Mondor
Créteil, France, 94010
CHU de Dijon
Dijon, France, 21079
CHU de Grenoble
Grenoble, France, 38700
Centre chirurgical Marie-Lannelongue
Le Plessis-Robinson, France, 92350
CHRU de Lille
Lille, France, 59037
AP-HM - Hôpital de la Timone
Marseille, France, 13385
CHRU de Montpellier
Montpellier, France, 34295
CHRU de Nancy
Nancy, France, 54500
CHU de Nantes
Nantes, France, 44000
Hôpital Européen Georges Pompidou
Paris, France, 75015
APHP - Hôpital Bichat
Paris, France
CHU de Rennes
Rennes, France, 35033
CHU de Rouen
Rouen, France, 76000
Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091
CHU de Toulouse
Toulouse, France
CHRU de Tours
Tours, France, 37170
Sponsors and Collaborators
Rennes University Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Rennes University Hospital
ClinicalTrials.gov Identifier: NCT02873169     History of Changes
Other Study ID Numbers: 35RC15_8806_ASSIST-ICD
First Posted: August 19, 2016    Key Record Dates
Last Update Posted: October 20, 2017
Last Verified: February 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Rennes University Hospital:
Left ventricular assist device
Ventricular Arrhythmias
Implantable Cardioverter-defibrillator
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases